Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Sensus Healthcare (SRTS) over the last 10 years, with Q3 2025 value amounting to $98000.0.

  • Sensus Healthcare's Depreciation & Amortization (CF) rose 8490.57% to $98000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $368000.0, marking a year-over-year increase of 7277.0%. This contributed to the annual value of $239000.0 for FY2024, which is 1309.09% down from last year.
  • According to the latest figures from Q3 2025, Sensus Healthcare's Depreciation & Amortization (CF) is $98000.0, which was up 8490.57% from $99000.0 recorded in Q2 2025.
  • In the past 5 years, Sensus Healthcare's Depreciation & Amortization (CF) ranged from a high of $389000.0 in Q2 2021 and a low of $31000.0 during Q2 2024
  • Its 5-year average for Depreciation & Amortization (CF) is $104052.6, with a median of $83000.0 in 2023.
  • Per our database at Business Quant, Sensus Healthcare's Depreciation & Amortization (CF) plummeted by 8097.69% in 2022 and then surged by 21935.48% in 2025.
  • Over the past 5 years, Sensus Healthcare's Depreciation & Amortization (CF) (Quarter) stood at $141000.0 in 2021, then plummeted by 47.52% to $74000.0 in 2022, then dropped by 20.27% to $59000.0 in 2023, then surged by 44.07% to $85000.0 in 2024, then grew by 15.29% to $98000.0 in 2025.
  • Its last three reported values are $98000.0 in Q3 2025, $99000.0 for Q2 2025, and $86000.0 during Q1 2025.